6901 logo

Diamond Biofund Inc. Stock Price

TWSE:6901 Community·NT$14.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6901 Share Price Performance

NT$0
-20.35 (-100.00%)
NT$0
-20.35 (-100.00%)
Price NT$0

6901 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks
0 Rewards

Diamond Biofund Inc. Key Details

-NT$863.2m

Revenue

NT$0

Cost of Revenue

-NT$863.2m

Gross Profit

NT$96.5m

Other Expenses

-NT$959.7m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-1.13
100.00%
111.18%
0%
View Full Analysis

About 6901

Founded
2013
Employees
29
CEO
Kung Lu
WebsiteView website
www.diamondbiofund.com/tc/index.htm

Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.

Recent 6901 News & Updates

Recent updates

No updates